Skip to main content

Analysts rely on company after weak results of Sun Pharma,know why?

Most brokerage firms rely on Sun Pharma, the country's largest pharmaceutical company. Even after weak results in the March quarter, analysts trust the company. However, they have cut its target price.



Sun Pharma had presented its March quarter results on Tuesday. Net profit of the company declined by 52.6 per cent to Rs 635.9 crore. The company's EBITDA also dropped 39.6 per cent to Rs 1,017 crore. Brokerage firms reduced its target price by 22 percent.

Brokerage, such as CLSA, HSBC, Jefferies and Reliance Securities, advised to buy this stock. But, its target price has been reduced by 3.7 per cent to 22 per cent. ICICI CicTits cuts target target by 7.6% However, its additional shopping advice is maintained.

Jefferies has advised buying it while explaining its risk and return ratio better. Brokerage has reduced its target price from 540 to 520 rupees. Reliance Securities has also advised to buy Sun Pharma by giving the same reason.

City has not made any change in the target price of Rs 540. The brokerage believes that the comments of the company management are very encouraging over the financial year 2019-20, but other issues remain.

Brokerage said, "The company management did not say anything on the issue of corporate governance nor did we comment on the ongoing dispute over prices in the US. We believe that these issues will remain in the future. There is not much good growth. "

Morgan Stanley does not trust this stock. This global analyst said, "Sun Pharma's generic business is stabilizing, but it is taking a lot of time in the specialty business in the US. We hope that the 2019-20 year will be the name of the specialty business."

For more information Best stock advisory Company in Indore

Comments

Popular posts from this blog

Keep 5-yr investment horizon for Long Term Equity Fund

Though the fund has done well over past five years, the investors must be prepared to tolerate short-term under performance in case there is a sudden rally that overlooks fundamentals . Investment strategy The scheme has invested in a concentrated portfolio of around 25 stocks. The stocks are picked up on a bottom-up basis. The fund manager identifies investment opportunities that would deliver over a five-year time frame. “We don’t put much emphasis on the macro environment and the associated factors since they are not predictable and not within anyone’s control.  Should you invest now? The scheme’s portfolio has cut its net exposure to Indian stocks over past two years. Compared to 62 percent in September 2016, it came down to 55 percent in September 2017 and to 45 percent now, in line with rising valuations of quality companies. High cash levels and exposure to overseas stocks have helped the fund to weather recent sharp correction in Indian stocks....

मेंथा ऑयल रेट टुडे: हफ्तेभर में 4% लुढ़का मेंथा, ₹1300 के नीचे जा सकता है भाव

मेंथा ऑयल का भाव एक हफ्ते में 4 फीसदी गिर चुका है. आगे भी कीमतों में तेज गिरावट के संकेत हैं. इसकी वजह नई फसल की आवक है. इस साल मेंथा का बंपर उत्पादन होने की उम्मीद है. कारोबारियों को जून में कीमतों में बड़ी गिरावट की आशंका है. मेंथा का सबसे ज्यादा उत्पादन उत्तर प्रदेश में होता है. ओरल केयर, फार्मास्युटिकल, परफ्यूम और कन्फेक्शनरी बनाने वाली कंपनियां मेंथा का इस्तेमाल करती हैं. मेंथा तेल की कीमतें पिछले महीने 1,360 रुपये प्रति किलोग्राम तक लुढ़क गईं. गुरुवार को एमसीएक्स पर मेंथा ऑयल का मई वायदा 0.20 फीसदी की गिरावट के साथ 1370 के आसपास कारोबार कर रहा था. वहीं दूसरे नजदीकी कॉन्ट्रैक्ट जून डिलीवरी का भाव 1,255 रुपये प्रति किलोग्राम पर कारोबार कर रहा था. एंजल ब्रोकिंग के डिप्टी वाइस प्रेसीडेंट (कमोडिटीज एवं करेंसी) अनुज गुप्ता ने कहा, 'हमें उम्मीद है कि आगे मेंथा ऑयल में गिरावट बढ़ सकती है. मई कॉन्ट्रैक्ट का भाव नीचे में 1,300-1,280 रुपये प्रति किलोग्राम तक गिर सकते हैं. कंपनियां मेंथॉल और क्रिस्टल बनाने के लिए भी मेंथा ऑयल का इस्तेमाल करती हैं. मेंथा को पुदीना भी क...

Government company MSTC is going to raise money from the primary market

IPO of Government Company MSTC Government company MSTC is going to raise money from the primary market. The company is going to introduce an IPO of Rs 226 crore. This IPO will open on March 13 (Wednesday). It can be invested till March 15 (Friday). The company has fixed the price band for the share price of 121-128. Through this IPO, the central government is going to sell its 1.76 crore shares of this company, which will be equal to 25 percent of its paid-up equity capital. After this IPO, the government's stake in the company will be reduced to 64.85 per cent, which is 8 per cent now. The company is headquartered in Kolkata. It filed a petition to present an IPO on February 1. Market regulator SEBI had given the green signal to the company on February 28 to present an IPO. The company has entrusted the management of Equity Capital to the issue management. The company started in the year 1964. The company is mainly active in the export of scraps. It has mini ratna st...